Breast cancer drug warning.
出版信息
Johns Hopkins Med Lett Health After 50. 2012 Dec;24(11):8.
PMID:23342677
Abstract
摘要
相似文献
1
Breast cancer drug warning.
Johns Hopkins Med Lett Health After 50. 2012 Dec;24(11):8.
2
Cardiotoxicity debated for anthracyclines and trastuzumab in breast cancer.
J Natl Cancer Inst. 2013 Jun 19;105(12):835-6. doi: 10.1093/jnci/djt161. Epub 2013 Jun 2.
3
Screening for cardiac risk before anthracycline administration: what are the real benefits?
Clin Breast Cancer. 2012 Feb;12(1):1-3. doi: 10.1016/j.clbc.2011.10.001. Epub 2011 Nov 29.
4
Cardiology patient page. Breast cancer chemotherapy and your heart.
Circulation. 2014 Jun 24;129(25):e680-2. doi: 10.1161/CIRCULATIONAHA.113.007181.
5
Trastuzumab before breast surgery? Large trial says yes but does not quell debate.
J Natl Cancer Inst. 2009 Apr 1;101(7):448-9. doi: 10.1093/jnci/djp072. Epub 2009 Mar 24.
6
[Therapy concept: herceptin with anthracyclines].
Onkologie. 2002 Dec;25 Suppl 5:19-21; discussion 21.
7
Women survive breast cancer but fall victim to heart failure: the shadows and lights of targeted therapy.
J Cardiovasc Med (Hagerstown). 2010 Dec;11(12):861-8. doi: 10.2459/JCM.0b013e328336b4c1.
8
Trastuzumab and congestive heart failure: what can we learn from use in the community?
J Natl Cancer Inst. 2012 Sep 5;104(17):1269-70. doi: 10.1093/jnci/djs342.
9
Trastuzumab-related cardiotoxicity following anthracycline-based adjuvant chemotherapy: how worried should we be?
J Clin Oncol. 2010 Jul 20;28(21):3407-10. doi: 10.1200/JCO.2009.26.0125. Epub 2010 Jun 7.
10
Cardiac issues related to trastuzumab.
Breast. 2004 Jun;13(3):171-2. doi: 10.1016/j.breast.2004.02.008.
Zotero 插件